Skip to main content
TipRanks
Go Ultimate75% OFF

JOHN DAVID HARRIS Insider Profile

4 Followers

JOHN DAVID HARRIS, VP and GM Cell Therapy at Cerenome, holds 0.00 shares in Cerenome (Ticker: CNSY). Most recently, JOHN DAVID HARRIS Bought 2,500 shares of Cerenome on Aug 11, 2016 for an estimated value of $5.08K.

JOHN DAVID HARRIS's Trading History

CNSY
Cerenome
Aug 11, 2016VP and GM Cell TherapyInformative Buy5.08K$0.00
CNSY
Insider Shares: 0.00 (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 11, 2016Informative Buy$5.08K2,500$2.03-82.10%
May 16, 2016Informative Buy$5.42K2,000$2.71-62.40%

You May Also Like

JOHN DAVID HARRIS insider profile FAQ

What is the percentage of profitable transactions made by JOHN DAVID HARRIS?
The percentage of profitable transactions made by JOHN DAVID HARRIS is 0%.
What is the average return per transaction made by JOHN DAVID HARRIS?
The average return per transaction made by JOHN DAVID HARRIS is -72.20%.
What stocks does JOHN DAVID HARRIS hold?
JOHN DAVID HARRIS holds: CNSY stocks.
What was JOHN DAVID HARRIS’s latest transaction?
JOHN DAVID HARRIS’s latest transaction was an Informative Buy of $5.08K.
What was JOHN DAVID HARRIS's most profitable transaction?
JOHN DAVID HARRIS’s most profitable transaction was an Informative Buy of CNSY stock on May 16, 2016. The return on the trade was -62.40%.
What is JOHN DAVID HARRIS's role in Cerenome?
JOHN DAVID HARRIS's role in Cerenome is VP and GM Cell Therapy.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.